Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: case report.

The journal of obstetrics and gynaecology research

Volumn 37, Issue 12, 2011, Pages 1864-1867

  Raspagliesi, Francesco ^a   Martinelli, Fabio ^b   Grijuela, Barbara ^b   Guadalupi, Valentina ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE;

ARTICLE; CASE REPORT; FEMALE; GRANULOSA CELL TUMOR; HUMAN; MIDDLE AGED; OVARY TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; FEMALE; GRANULOSA CELL TUMOR; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84864011864     PISSN: None     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01649.x     Document Type: Article

References (0)